Search Results
Should you treat Lupus patients with Anifrolumab?
Richard Furie, MD, Talks About Anifrolumab Treatment in Patients with SLE
FDA approval of anifrolumab for SLE | Eric Morand
Anifrolumab efficacy and safety by type I IFNGS and clinical subgroups in patients with SLE
Anifrolumab and Oral Deucravacitinib shows promise in patients with lupus
Anifrolumab modulates key immune pathways in patients with systemic lupus erythematosus (SLE)
HSS Annual Report 2021 | Dr. Peggy Crow Shares Her Perspective on Anifrolumab Approval
AstraZeneca - FDA Approval of Saphnelo™ (anifrolumab) For Lupus Erythematosus (SLE)
Dr Hillary Norton | SAPHNELO® (anifrolumab-fnia) LTE Safety Study
RheumNow Podcast – Saphnelo (Anifrolumab) Approved for Lupus (8.6.2021)
Newer treatments in Systemic Lupus Erythematosus (SLE)
Dr Alan L. Epstein | How SAPHNELO® (anifrolumab-fnia) Works
